IU Simon Cancer Center

National Recognition

The Indiana University Melvin and Bren Simon Cancer Center is the only NCI-designated comprehensive cancer center in Indiana and one of just 51 in the nation. The comprehensive designation is the highest level of recognition awarded by the National Cancer Institute, the federal government’s principal agency for cancer research and training, and is the gold standard for cancer centers.

In 2019, NCI reviewers rated IU Simon Cancer Center as “outstanding” and awarded a five-year, $13.8 million grant to support the center’s research programs and shared equipment and resources.

What does a Comprehensive designation from the NCI mean?

The comprehensive designation recognizes programs with an exceptional depth and breadth of research, substantial transdisciplinary research that bridges scientific areas, and an effective community outreach program across the state. This distinction further enhances Indiana University’s ability to recruit faculty physicians and scientists of the highest caliber, who will bring with them highly funded research programs and continue to foster a culture of entrepreneurship in Indiana.

The acting director of the National Cancer Institute, Dr. Douglas Lowy, explained that designated cancer centers are recognized for their state-of-the-art research programs and strong commitment to delivering cutting-edge cancer treatment for patients. They are at the core of the nation’s cancer research effort.

This acknowledgment places Indiana University in the company of institutions such as the University of Texas MD Anderson Cancer Center, Dana-Farber/Harvard Cancer Center, Memorial Sloan-Kettering Cancer Center and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.